CH564509A5 - - Google Patents

Info

Publication number
CH564509A5
CH564509A5 CH477773A CH477773A CH564509A5 CH 564509 A5 CH564509 A5 CH 564509A5 CH 477773 A CH477773 A CH 477773A CH 477773 A CH477773 A CH 477773A CH 564509 A5 CH564509 A5 CH 564509A5
Authority
CH
Switzerland
Application number
CH477773A
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1962497A external-priority patent/DE1962497C3/de
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of CH564509A5 publication Critical patent/CH564509A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CH477773A 1969-12-12 1970-12-09 CH564509A5 (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1962497A DE1962497C3 (de) 1969-12-12 1969-12-12 Naphthylalkyl- a -hydroxyphenäthyl-amine, ihre Herstellung und diese enthaltende Arzneimittel
CH1818970A CH556322A (de) 1969-12-12 1970-12-09 Verfahren zur herstellung von neuen naphthylalkylaminen.

Publications (1)

Publication Number Publication Date
CH564509A5 true CH564509A5 (he) 1975-07-31

Family

ID=25720616

Family Applications (2)

Application Number Title Priority Date Filing Date
CH477773A CH564509A5 (he) 1969-12-12 1970-12-09
CH477673A CH556323A (de) 1969-12-12 1970-12-09 Verfahren zur herstellung von neuen naphthylalkylaminen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH477673A CH556323A (de) 1969-12-12 1970-12-09 Verfahren zur herstellung von neuen naphthylalkylaminen.

Country Status (1)

Country Link
CH (2) CH564509A5 (he)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317206A2 (en) * 1987-11-13 1989-05-24 Glaxo Group Limited Phenethanolamine derivatives
WO2008022038A1 (en) * 2006-08-10 2008-02-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
US10130594B2 (en) 2010-03-10 2018-11-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0317206A2 (en) * 1987-11-13 1989-05-24 Glaxo Group Limited Phenethanolamine derivatives
EP0317206A3 (en) * 1987-11-13 1990-02-07 Glaxo Group Limited Phenethanolamine derivatives
WO2008022038A1 (en) * 2006-08-10 2008-02-21 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Preparation of (r,r)-fenoterol and (r,r)- or (r,s)-fenoterol analogues and their use in treating congestive heart failure
US10562843B2 (en) 2006-08-10 2020-02-18 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure
US10130594B2 (en) 2010-03-10 2018-11-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
US10617654B2 (en) 2010-03-10 2020-04-14 The Usa, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas
US10925840B2 (en) 2010-03-10 2021-02-23 The Usa, As Represented By The Secretary, Department Of Health And Human Services Use of fenoterol and fenoterol analogues in the treatment of glioblastomas and astrocytomas

Also Published As

Publication number Publication date
CH556323A (de) 1974-11-29

Similar Documents

Publication Publication Date Title
AU465413B2 (he)
AU450150B2 (he)
AU2355770A (he)
AU442375B2 (he)
AU470301B1 (he)
AU5113869A (he)
AU442554B2 (he)
AU442535B2 (he)
AU442380B2 (he)
AU442538B2 (he)
AT308690B (he)
AU470661B1 (he)
AU442463B2 (he)
CS151019B2 (he)
CS148490B1 (he)
AU4949169A (he)
AU1036070A (he)
AR203167Q (he)
AU4540468A (he)
AU5109569A (he)
AU5077469A (he)
CS151610B1 (he)
CH1031769A4 (he)
AU4982068A (he)
AU4953367A (he)

Legal Events

Date Code Title Description
PL Patent ceased